Vanguard Health Care Inv
(VGHCX)
+0.70
+0.41%
| Symbol | Value ($) |
|---|---|
| Morningstar Rating | |
| Previous Close | 169.66 |
| Category | Health |
| Net Assets | 9.57 Bil |
| Yield | 1.58% |
| Morningstar Risk | Low |
| Morningstar Return | Average |
- Last NAV update 5/17/2013 4:00 PM ET
| NA |
|---|
| The investment seeks long-term capital appreciation. The fund invests at least 80% of its assets in the stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry. These companies include, among others, pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities. It also considers companies engaged in medical, diagnostic, biochemical, and other research and development activities. The fund may invest up to 50% of its assets in foreign stocks. |
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Return | 20.96% | 6.16% | 11.45% | 15.11% | 21.88% |
| Value ($) | 12,096.00 | 12,841.11 | 14,311.42 | 16,473.88 | 20,078.36 |
- Year to date performance as of 5/16/2013 8:00 PM ET
| Symbol | Value ($) |
|---|---|
| Fund Family | Vanguard |
| Fund Manager | Jean Hynes |
| Tenure (Years) | 5 |
| Fund Status | Open |
| Minimum Initial Purchase | 3,000.00 |
| Minimum IRA Investment | NA |
| Front Load | 0.00 |
| Expense Ratio | 0.35% |
| Symbol | Value ($) |
|---|---|
| 1 Month | 4.64% |
| 3 Months | 13.64% |
| 1 Year | 35.03% |
| 3 Years* | 19.82% |
| 5 Years* | 11.98% |
- * Annualized returns
- Performance as of 5/16/2013 8:00 PM ET
| VGHCX | Health | |
|---|---|---|
| 5-Yr Return | 11.98% | 12.34% |
| Sharpe Ratio | 1.53 | 1.13 |
| Net Assets | 9.57 Bil | 504.34 Mil |
| Avg Market Cap | 31.80 Bil | 18.61 Bil |
| Avg P/E | 18.05 | 18.60 |
| Portfolio Turnover | 8 | 48 |
| Symbol | Value ($) |
|---|---|
| Stocks | 96.17% |
| Cash | 0.00% |
| Fixed Income | 0.02% |
| Other | 3.81% |
| NAME | % NET ASSETS |
|---|---|
| Merck & Co Inc | 6.02% |
| Amgen Inc | 4.47% |
| UnitedHealth Group Inc | 4.17% |
| Forest Laboratories, Inc. | 3.80% |
| Roche Holding AG | 3.68% |
| McKesson, Inc. | 3.50% |
| Pfizer Inc | 3.46% |
| Eli Lilly and Company | 3.31% |
| Astellas Pharma, Inc. | 2.93% |
| AstraZeneca PLC | 2.85% |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
